VUB Generali dochodkova spravcovska spolocnost’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$227K Hold
5,400
0.16% 84
2026
Q1
$143K Hold
5,400
0.11% 88
2025
Q4
$156K Buy
+5,400
New +$162K 0.12% 91

Other funds holding ARKG

VUB Generali dochodkova spravcovska spolocnost's ARKG Position: Q2 2026 in Review

VUB Generali dochodkova spravcovska spolocnost held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 5,400 shares worth $227K. The position accounts for 0.16% of the portfolio, ranked #84.

VUB Generali dochodkova spravcovska spolocnost first reported a position in ARKG in Q4 2025 and has held it in 3 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • VUB Generali dochodkova spravcovska spolocnost held 5,400 shares of ARK Genomic Revolution ETF worth $227K as of Q2 2026.
  • VUB Generali dochodkova spravcovska spolocnost left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
  • ARK Genomic Revolution ETF made up 0.16% of VUB Generali dochodkova spravcovska spolocnost's portfolio in Q2 2026, its #84 holding.
  • VUB Generali dochodkova spravcovska spolocnost first reported a position in ARK Genomic Revolution ETF in Q4 2025 and has held it in 3 quarters since.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on VUB Generali dochodkova spravcovska spolocnost's 13F filing for Q2 2026, filed 23 Jul 2026.